Qlife Holding AB (OSTO:QLIFE) YoY EBITDA Growth: 61.42% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:QLIFE Qlife Holding AB OSTO:QLIFE
35 GF Score
Price kr1.69
GF Value kr1.37
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Qlife Holding AB YoY EBITDA Growth?

Qlife Holding AB OSTO:QLIFE +4.33% 35 YoY EBITDA Growth is 61.42% as of Jun. 2026. GuruFocus rates OSTO:QLIFE with a GF Score™ of 35/100 and a GF Value™ of kr1.37 (Modestly Overvalued). The stock has 9 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Qlife Holding AB's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 61.42%.

Qlife Holding AB's EBITDA per Share for the three months ended in Jun. 2026 was kr-0.22.

Qlife Holding AB YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Qlife Holding AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qlife Holding AB YoY EBITDA Growth Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial -48.94 -88.58 66.22 84.76 96.98

Qlife Holding AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.36 -11,316.67 95.53 -1.28 61.42
OSTO:QLIFE
35GF Score
Qlife Holding AB OSTO:QLIFE
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qlife Holding AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Qlife Holding AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-2.246--74.258)/ | -74.258 |
=96.98 %

Qlife Holding AB's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(-0.223--0.578)/ | -0.578 |
=61.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 61.42% mean?
Qlife Holding AB (OSTO:QLIFE) has a YoY EBITDA Growth of 61.42% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Qlife Holding AB and its competitors.
Is Qlife Holding AB's YoY EBITDA Growth too high?
Qlife Holding AB's current YoY EBITDA Growth is 61.42%. Overall, Qlife Holding AB has a GF Score™ of 35/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's YoY EBITDA Growth compare to ABT and SYK?
Qlife Holding AB's YoY EBITDA Growth of 61.42% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Qlife Holding AB and its competitors. Qlife Holding AB's current YoY EBITDA Growth is 61.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (OSTO:QLIFE) is currently considered Modestly Overvalued. The stock's GF Value™ is kr1.37, compared to a current price of kr1.69 — trading 23.1% above its estimated fair value. The current YoY EBITDA Growth is 61.42%. Qlife Holding AB's overall GF Score™ is 35/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Qlife Holding AB (OSTO:QLIFE), the current YoY EBITDA Growth is 61.42% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qlife Holding AB (OSTO:QLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued. The current stock price of kr1.69 is trading 23.1% above its estimated GF Value™ of kr1.37. GuruFocus considers Qlife Holding AB to be Modestly Overvalued.

Key valuation signals for OSTO:QLIFE:

  • YoY EBITDA Growth: 61.42%
  • GF Value™: kr1.37 vs. price of kr1.69 (23.1% above fair value)
  • GF Score™: 35/100 with 9 warning signs

No single metric tells the full story. See the OSTO:QLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qlife Holding AB Business Description

Other Exchanges 4HG0:Germany
Address Nellikevagen 22, Goteborg, SWE, SE-412 63
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
35GF Score

Get the complete analysis for OSTO:QLIFE

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.69
Price
kr1.37
GF Value